- Home
- TCRX vs AHMA Comparison
TCRX vs AHMA Comparison
Compare TCRX & AHMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | AHMA |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United Arab Emirates |
| Employees | N/A | 44 |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 74.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TCRX | AHMA |
|---|---|---|
| Price | $0.98 | $1.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 509.6K | ★ 6.1M |
| Earning Date | 05-08-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,325,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | $180.72 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.83 | $0.76 |
| 52 Week High | $2.57 | $39.50 |
Technical Indicators
Market Signals| Indicator | TCRX | AHMA |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 52.67 |
| Support Level | $0.90 | $0.96 |
| Resistance Level | $1.16 | $5.40 |
| Average True Range (ATR) | 0.09 | 0.69 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 61.86 | 11.89 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.